Pathological, excessive neovascularization is the primary cause of blindness in proliferative diabetic retinopathy (PDR). In general, vascular remodeling and angiogenesis is required for the progression of diabetes and many other life-threatening diseases. Our long-term research goal is to elucidate the complex, multivariate regulatory mechanisms governing pathological angiogenesis and vascular remodeling by analyzing change in vascular pattern as a read-out of molecular regulation. In preliminary studies using our novel region-based fractal analysis, vascular density decreased during nonproliferative diabetic retinopathy (NPDR) prior to the excessive neovascularization that clinically defines progression to PDR. We therefore propose to first validate the hypothesis that (1) vascular density decreases during NPDR prior to the pathological neovascularization of PDR, and further test that (2) the initial decrease in vascular density during NPDR may be reversible with promising, new anti-angiogenic therapeutics currently undergoing clinical trials for treatment of diabetic retinopathy. To test our hypothesis, the following questions posed in Specific Aims will be answered by region-based fractal analysis: (1) How do blood vessels remodel during early-stage, non-proliferative diabetic retinopathy (NPDR) prior to the pathological neovascularization that defines late-stage, proliferative diabetic retinopathy (PDR)? Does vascular density continue to decrease during progression from mild to severe NPDR? Prospective clinical studies of the NPDR human retina will be performed. (2) Can the molecular regulation of vascular remodeling during NPDR by promising steroids and other anti-VEGF inhibitors be deduced and quantified by region-based fractal analysis? Effects of the steriod triamcinolone acetonide will be quantified in the NPDR human retina and in another 2D, optically accessible tissue of similar vascular morphology, the quail chorioallantoic membrane (CAM). Currently it is not known how blood vessels remodel during NPDR, although capillary dropout during NPDR is well established. To study how blood vessels remodel in the 2D, optically accessible NPDR human retina, we are applying fractal techniques first developed in the CAM. The CAM continues to serve as a convenient testbed for ongoing development of fractal methods and for examination of effects of human regulators on angiogenesis and vascular remodeling.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY017529-02
Application #
7128994
Study Section
Special Emphasis Panel (ZDK1-GRB-4 (O1))
Program Officer
Mariani, Andrew P
Project Start
2005-09-30
Project End
2009-08-31
Budget Start
2006-09-01
Budget End
2009-08-31
Support Year
2
Fiscal Year
2006
Total Cost
$146,475
Indirect Cost
Name
Nasa - Glenn Research Center
Department
Type
DUNS #
004523320
City
Cleveland
State
OH
Country
United States
Zip Code
44135
Parsons-Wingerter, Patricia; Radhakrishnan, Krishnan; Vickerman, Mary B et al. (2010) Oscillation of angiogenesis with vascular dropout in diabetic retinopathy by VESsel GENeration analysis (VESGEN). Invest Ophthalmol Vis Sci 51:498-507
Vickerman, Mary B; Keith, Patricia A; McKay, Terri L et al. (2009) VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks. Anat Rec (Hoboken) 292:320-32
Liu, Hongbin; Yang, Qiwei; Radhakrishnan, Krishnan et al. (2009) Role of VEGF and tissue hypoxia in patterning of neural and vascular cells recruited to the embryonic heart. Dev Dyn 238:2760-9
McKay, Terri L; Gedeon, Dan J; Vickerman, Mary B et al. (2008) Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonide. Invest Ophthalmol Vis Sci 49:1184-90